Publications of A. Zimmermann

Opitz, L., Zimmermann, A., Lehmann, S., Genzel, Y., Lübben, H., Reichl, U., & Wolff, M. W. (2008)Capture of cell culture-derived influenza virus by lectins: strain independent, but host cell dependentJournal of Virological Methods, 154 (1-2), 61–68doi: 10.1016/j.jviromet.2008.09.004.

Kalbfuss, B., Genzel, Y., Wolff, M. W., Zimmermann, A., Morenweiser, R., & Reichl, U. (2007)Harvesting and concentration of human influenza A virus produced in serum-free mammalian cell culture for the production of vaccinesBiotechnology and Bioengineering, 97 (1), 73–85doi: 10.1002/bit.21139.

Opitz, L., Lehmann, S., Zimmermann, A., Reichl, U., & Wolff, M. W. (2007)Impact of adsorbents selection on affinity purification efficiency of cell culture derived human Influenza virusesJournal of Biotechnology, 131 (3), 309–317doi: 10.1016/j.jbiotec.2007.07.723.

Wickramasinghe, S. R., Kalbfuss, B., Zimmermann, A., Thom, V., & Reichl, U. (2005)Tangential flow microfiltration and ultrafiltration for human influenza A virus concentration and purificationBiotechnology and Bioengineering, 92 (2), 199–208doi: 10.1002/bit.20599.

Kröber, T., Wolff, M. W., Lehmann, S., Zimmermann, A., & Reichl, U. (2012)Accounting for the Entire Influenza Hemagglutinin during a Flu Vaccine Production ProcessIn: ESACT - Proceedings of the 21st Annual meeting of the European Society for animal cell technology (ESACT), 685–689doi: 10.1007/978-94-007-0884-6_108.

Opitz, L., Lehmann, S., Zimmermann, A., Hohlweg, J., Reichl, U., & Wolff, M. W.Affinity capture of cell culture-derived influenza virus particlesPresented at: Prep 2009Philadelphia, USA, July 19, 2009.

Kröber, T., Lehmann, S., Solf, N., Zimmermann, A., Reichl, U., & Wolff, M. W.Purification of Hemagglutinin from Host Cell MembranesPresented at: ISPPP 2008Baden-Baden, Germany, September 21, 2008.

Opitz, L., Zimmermann, A., Genzel, Y., Lübben, H., Reichl, U., & Wolff, M. W.Lectin-affinity chromatography: a novel purification method for cell culture based Influenza vaccine production from the current season 2006/07Presented at: European BioPerspectives 2007Cologne, Germany, May 30, 2007.

Opitz, L., Zimmermann, A., Genzel, Y., Lübben, H., Reichl, U., & Wolff, M. W.Lektin-Affinitätschromatographie - Neuartige Methode zur Aufreinigung humaner Influenza Viren aus Zellkulturen zur ImpfstoffproduktionPresented at: DECHEMA/GVC Vortrag- und Diskussionstagung "Aufarbeitung biotechnologischer Produkte"Osnabrück, Germany, May 13, 2007.

Opitz, L., Zimmermann, A., Lehmann, S., Genzel, Y., Lübben, H., Reichl, U., & Wolff, M. W.Efficient influenza virus capture from cell cultivation broth by a novel affinity chromatographyPresented at: AIChE Annual meeting 2007Salt Lake City, USA, November 4, 2007.

Opitz, L., Zimmermann, A., Lehmann, S., Genzel, Y., Lübben, H., Reichl, U., & Wolff, M. W.Novel capturing method for currently spread influenza viruses from cell cultures by affinity separationPresented at: ISPPP 2007Orlando, USA, October 21, 2007.

Kalbfuss, B., Wolff, M. W., Genzel, Y., Zimmermann, A., Best, C., Morenweiser, R., & Reichl, U.A generic purification scheme for the production of human influenza vaccines derived from serum-free mammalian cell culturePresented at: Vaccine TechnologyPuerto Vallarta, Mexico, June 25, 2006.

Kalbfuss, B., Wolff, M. W., Genzel, Y., Zimmermann, A., Morenweiser, R., & Reichl, U.Chromatography-based purification of influenza A virus for the production of human whole-virion vaccinesPresented at: ISPPP 2006 : 26th International Symposium on the Separation of Proteins, Peptides and PolynucleotidesInnsbruck, Austria, October 17, 2006.

Wolff, M. W., Kalbfuss, B., Lehmann, S., Morenweiser, R., Opitz, L., Zimmermann, A., & Reichl, U.Downstream Processes and Glycan Characterization of MDCK-Cell Derived Influenza VirusPresented at: BioProcess Technology - AsiaSingapore, June 26, 2006.

Wolff, M. W., Kalbfuss, B., Opitz, L., Zimmermann, A., Lehmann, S., & Reichl, U.Downstream Process of Influenza VirusesPresented at: European BioPharm Scale-Up Congress 2006Geneva, Switzerland, September 12, 2006.

Wolff, M., Kalbfuss, B., Morenweiser, R., Zimmermann, A., & Reichl, U.Chromatography-based Purification of Influenza A Virus for the Production of Human Whole-Virion VaccinesPresented at: Viral Vectors and Vaccines ConferenceAustin, Texas, November 14, 2005.

Kröber, T., Wolff, M. W., Lehmann, S., Zimmermann, A., & Reichl, U.Accounting for the Entire Influenza Hemagglutinin During a Flu Vaccine Production ProcessPresented at: 21st ESACT MeetingDublin, Ireland, June 7, 2009.

Opitz, L., Zimmermann, A., Genzel, Y., Lübben, H., Reichl, U., & Wolff, M. W.Lectin-affinity chromatography for downstream processing of current influenza virus strains from MDCK and Vero cell cultivationsPresented at: AIChE Annual meeting 2007Salt Lake City, USA, November 4, 2007.

Kalbfuss, B., Zimmermann, A., Genzel, Y., & Reichl, U.Generic Process Scheme for Particle-Based Purification of Cell Culture Derived Influenza A VirusPresented at: BioperspectivesWiesbaden, Germany, May 10, 2005.

Kalbfuss, B., Zimmermann, A., Wickramasinghe, B., Morenweiser, R., & Reichl, U.Tangential Flow Filtration of Influenza Virus as a Model SystemPresented at: Engineering with MembranesCamogli, Italy, May 22, 2005.